NET (LOSS) INCOME PER COMMON SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Numerator [Abstract]
Net income	$ 259	$ 272	$ 2,426	$ 4,489	$ 532	$ 6,915
Less: preferred stock dividend	(304)		(304)		(608)	(608)
Less: allocation to preferred stockholders	0		(349)		0	(1,046)
Less: allocation to restricted stockholders	0		(143)		0	(403)
Net (loss) income allocated to common stockholders	$ (45)		$ 1,630		$ (76)	$ 4,858
Denominator [Abstract]
Weighted average common shares outstanding (in shares)	25,962,617		25,105,238		25,842,456	24,996,583
Basic (loss) income per share (in dollars per share)	$ 0.00		$ 0.06		$ 0.00	$ 0.19
Denominator [Abstract]
Weighted average number of common shares outstanding (in shares)	25,962,617		25,105,238		25,842,456	24,996,583
Diluted shares outstanding (in shares)	25,962,617		25,105,238		25,842,456	24,996,583
Diluted (loss) income per share (in dollars per share)	$ 0.00		$ 0.06		$ 0.00	$ 0.19
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of loss per share (in shares)	6,928,480		6,342,233		6,981,247	6,209,920
Series A Preferred Stock [Member]
Denominator [Abstract]
Dilutive potential common shares outstanding (in shares)	0		0		0	0
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of loss per share (in shares)	5,381,356		5,381,356		5,381,356	5,381,356
Unvested Restricted Stock [Member]
Denominator [Abstract]
Dilutive potential common shares outstanding (in shares)	0		0		0	0
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of loss per share (in shares)	1,547,124		960,877		1,599,891	828,564